|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Captafol | CAS 2425-06-1 | ||
| C10H9Cl14NO2S | RTECS GS4900000 | ||
|
Synonyms & Trade Names Captofol; Difolatan®; N-((1,1,2,2-Tetrachloroethyl)thio)-4-cyclohexene-1,2-dicarboximide |
DOT ID & Guide |
||
|
Exposure Limits |
NIOSH REL: Ca TWA 0.1 mg/m3 [skin] See Appendix A | ||
| OSHA PEL�: none | |||
| IDLH Ca [N.D.] | Conversion | ||
|
Physical Description White, crystalline solid with a slight, characteristic pungent odor. [fungicide] [Note: Available commercially as a wettable powder or in liquid form.] |
|||
|
MW: 349.1 |
BP: Decomposes |
MLT: 321°F (Decomposes) |
Sol: 0.0001% |
|
VP: 0.000008 mmHg |
IP: NA |
Sp.Gr: ? |
|
|
Fl.P: NA |
UEL: NA |
LEL: NA |
|
| Noncombustible Solid, but may be dissolved in flammable liquids. | |||
|
Incompatibilities & Reactivities Acids, acid vapors, strong oxidizers |
|||
|
Measurement Methods NIOSH 0500 |
|
Personal Protection & Sanitation Skin: Prevent skin contact Eyes: Prevent eye contact Wash skin: When contaminated/Daily Remove: When wet or contaminated Change: Daily Provide: Eyewash, Quick drench |
First Aid (See procedures) Eye: Irrigate immediately Skin: Soap wash immediately Breathing: Respiratory support Swallow: Medical attention immediately |
|
Respirator Recommendations
NIOSH At concentrations above the NIOSH REL, or where there is no REL, at any detectable concentration: (APF = 10,000) Any self-contained breathing apparatus that has a full facepiece and is operated in a pressure-demand or other positive-pressure mode/(APF = 10,000) Any supplied-air respirator that has a full facepiece and is operated in a pressure-demand or other positive-pressure mode in combination with an auxiliary self-contained positive-pressure breathing apparatus Escape: (APF = 50) Any air-purifying, full-facepiece respirator (gas mask) with a chin-style, front- or back-mounted organic vapor canister/Any appropriate escape-type, self-contained breathing apparatus |
|
| Exposure Routes inhalation, skin absorption, ingestion, skin and/or eye contact | |
| Symptoms Irritation eyes, skin, respiratory system; dermatitis, skin sensitization; conjunctivitis; bronchitis, wheezing; diarrhea, vomiting; liver, kidney injury; high blood pressure; in animals: teratogenic effects; [potential occupational carcinogen] | |
|
Target Organs
Eyes, skin, respiratory system, central nervous system, liver, kidneys, cardiovascular system Cancer Site [in animals: tumors at many sites] |
|
| See also: INTRODUCTION |